Search our extensive Laboratory Test Directory to find test codes, ordering recommendations, specimen stability information, Test Fact Sheets, and more.
Recommendations when to order or not order the test. May include related or preferred tests.
Use to optimize drug therapy and monitor patient adherence.
New York DOH Approval Status
Indicates whether a test has been approved by the New York State Department of Health.
This test is New York state approved.
Specimen Required
Patient PreparationInstructions patient must follow before/during specimen collection.
Timing of specimen collection: Predose (trough) draw - At steady state concentration.
CollectSpecimen type to collect. May include collection media, tubes, kits, etc.
Plain red. Also acceptable: Lavender (K2 or K3EDTA), pink (K2EDTA), green (Heparin) or gray (Potassium oxalate or Sodium fluoride).
Specimen PreparationInstructions for specimen prep before/after collection and prior to transport.
Separate serum or plasma from cells within 2 hours of collection. Transfer 2 mL serum or plasma to an ARUP Standard Transport Tube. (Min: 0.5 mL)
Storage/Transport TemperaturePreferred temperatures for storage prior to and during shipping to ARUP. See Stability for additional info.
Frozen.
Unacceptable ConditionsCommon conditions under which a specimen will be rejected.
Whole blood. Hemolyzed specimens. Gel separator tubes, light blue (citrate) or yellow (SPS or ACD solution).
RemarksAdditional specimen collection, transport, or test submission information.
StabilityAcceptable times/temperatures for specimens. Times include storage and transport time to ARUP.
After separation from cells: Ambient: Unacceptable; Refrigerated: 14 days; Frozen: 14 days
Methodology
Process(es) used to perform the test.
Quantitative Liquid Chromatography-Tandem Mass Spectrometry
Performed
Days of the week the test is performed.
Mon
Reported
Expected turnaround time for a result, beginning when ARUP has received the specimen.
1-8 days
Reference Interval
Normal range/expected value(s) for a specific disease state. May also include abnormal ranges.
Therapeutic Range
30-300 ng/mL
Toxic Level
Greater than or equal to 600 ng/mL
Interpretive Data
May include disease information, patient result explanation, recommendations, or details of testing.
Chlorpromazine is a neuroleptic drug indicated for the treatment of schizophrenia, psychotic disorders and intractable hiccup. Chlorpromazine should not be used in patients who have epilepsy, Parkinson's disease, hypoparathyroidism, myasthenia gravis, and prostatic hypertrophy. Adverse effects may include drowsiness, hypotension, agranulocytosis, cardiac abnormalities, seizures and rare life-threatening effects, such as phenothiazine sudden death syndrome, and neuroleptic malignant syndrome.
Compliance Category
Laboratory Developed Test (LDT)
Note
Additional information related to the test.
Hotline History
N/A
CPT Codes
The American Medical Association Current Procedural Terminology (CPT) codes published in ARUP's Laboratory Test Directory are provided for informational purposes only. The codes reflect our interpretation of CPT coding requirements based upon AMA guidelines published annually. CPT codes are provided only as guidance to assist clients with billing. ARUP strongly recommends that clients confirm CPT codes with their Medicare administrative contractor, as requirements may differ. CPT coding is the sole responsibility of the billing party. ARUP Laboratories assumes no responsibility for billing errors due to reliance on the CPT codes published.
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.
Connect Sign In
